Burton, E. R., Brady, M., Homesley, H. D., Rose, P. G., Nakamura, T., Kesterson, J. P., . . . Van Le, L. (2016). A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study. Gynecologic Oncology, 140(1), 48. https://doi.org/10.1016/j.ygyno.2015.11.027
Chicago Style (17th ed.) CitationBurton, Elizabeth R., Mark Brady, Howard D. Homesley, Peter G. Rose, Toshiaki Nakamura, Joshua P. Kesterson, Jacob Rotmensch, J. Tate Thigpen, and Linda Van Le. "A Phase II Study of Paclitaxel for the Treatment of Ovarian Stromal Tumors: An NRG Oncology/ Gynecologic Oncology Group Study." Gynecologic Oncology 140, no. 1 (2016): 48. https://doi.org/10.1016/j.ygyno.2015.11.027.
MLA (9th ed.) CitationBurton, Elizabeth R., et al. "A Phase II Study of Paclitaxel for the Treatment of Ovarian Stromal Tumors: An NRG Oncology/ Gynecologic Oncology Group Study." Gynecologic Oncology, vol. 140, no. 1, 2016, p. 48, https://doi.org/10.1016/j.ygyno.2015.11.027.